172 related articles for article (PubMed ID: 36394206)
1. Alternative splicing of HSPA12A pre-RNA by SRSF11 contributes to metastasis potential of colorectal cancer.
Pan YJ; Huo FC; Kang MJ; Liu BW; Wu MD; Pei DS
Clin Transl Med; 2022 Nov; 12(11):e1113. PubMed ID: 36394206
[TBL] [Abstract][Full Text] [Related]
2. Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1.
Du JX; Luo YH; Zhang SJ; Wang B; Chen C; Zhu GQ; Zhu P; Cai CZ; Wan JL; Cai JL; Chen SP; Dai Z; Zhu W
J Exp Clin Cancer Res; 2021 May; 40(1):171. PubMed ID: 33992102
[TBL] [Abstract][Full Text] [Related]
3. SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.
Wan L; Yu W; Shen E; Sun W; Liu Y; Kong J; Wu Y; Han F; Zhang L; Yu T; Zhou Y; Xie S; Xu E; Zhang H; Lai M
Gut; 2019 Jan; 68(1):118-129. PubMed ID: 29114070
[TBL] [Abstract][Full Text] [Related]
4. HSPA12A was identified as a key driver in colorectal cancer GWAS loci 10q26.12 and modulated by an enhancer-promoter interaction.
Lu Z; Fan L; Zhang F; Huang C; Cai Y; Chen C; Li G; Zhang M; Huang J; Ning C; Li Y; Wang W; Geng H; Liu Y; Chen S; Li H; Yang S; Zhang H; Tian W; Ye T; Liu J; Yang X; Xu B; Zhu Y; Zhong R; Li H; Tian J; Li B; Miao X
Arch Toxicol; 2023 Jul; 97(7):2015-2028. PubMed ID: 37245169
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of RNA-binding protein SRSF2-dependent alternative splicing signature in malignant proliferation of colorectal carcinoma.
Liu W; Li D; Lu T; Zhang H; Chen Z; Ruan Q; Zheng Z; Chen L; Guo J
J Biol Chem; 2023 Feb; 299(2):102876. PubMed ID: 36623729
[TBL] [Abstract][Full Text] [Related]
6. SF3B3-regulated mTOR alternative splicing promotes colorectal cancer progression and metastasis.
Xu T; Li X; Zhao W; Wang X; Jin L; Feng Z; Li H; Zhang M; Tian Y; Hu G; Yue Y; Dai X; Shan C; Zhang W; Zhang C; Zhang Y
J Exp Clin Cancer Res; 2024 Apr; 43(1):126. PubMed ID: 38671459
[TBL] [Abstract][Full Text] [Related]
7. Long-read sequencing reveals the landscape of aberrant alternative splicing and novel therapeutic target in colorectal cancer.
Sun Q; Han Y; He J; Wang J; Ma X; Ning Q; Zhao Q; Jin Q; Yang L; Li S; Li Y; Zhi Q; Zheng J; Dong D
Genome Med; 2023 Sep; 15(1):76. PubMed ID: 37735421
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel alternative splicing isoform biomarkers and their association with overall survival in colorectal cancer.
Lian H; Wang A; Shen Y; Wang Q; Zhou Z; Zhang R; Li K; Liu C; Jia H
BMC Gastroenterol; 2020 Jun; 20(1):171. PubMed ID: 32503434
[TBL] [Abstract][Full Text] [Related]
9. METTL3-mediated downregulation of splicing factor SRSF11 is associated with carcinogenesis and poor survival of cancer patients.
Oh J; Oh JM; Cho SY
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(6):2561-2570. PubMed ID: 37013774
[TBL] [Abstract][Full Text] [Related]
10. RBM4-SRSF3-MAP4K4 splicing cascade modulates the metastatic signature of colorectal cancer cell.
Lin JC; Lee YC; Tan TH; Liang YC; Chuang HC; Fann YC; Johnson KR; Lin YJ
Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):259-272. PubMed ID: 29138007
[TBL] [Abstract][Full Text] [Related]
11. HSPA12A unstabilizes CD147 to inhibit lactate export and migration in human renal cell carcinoma.
Min X; Zhang X; Li Y; Cao X; Cheng H; Li Y; Li C; Kong Q; Mao Q; Peng P; Ni Y; Li J; Duan Y; Liu L; Ding Z
Theranostics; 2020; 10(19):8573-8590. PubMed ID: 32754264
[No Abstract] [Full Text] [Related]
12. CircPLCE1 facilitates the malignant progression of colorectal cancer by repressing the SRSF2-dependent PLCE1 pre-RNA splicing.
Chen Z; Chen H; Yang L; Li X; Wang Z
J Cell Mol Med; 2021 Aug; 25(15):7244-7256. PubMed ID: 34173324
[TBL] [Abstract][Full Text] [Related]
13. Heat-Shock protein A12A is a novel PCNA-binding protein and promotes hepatocellular carcinoma growth.
Cheng H; Cao X; Min X; Zhang X; Kong Q; Mao Q; Li R; Xue B; Fang L; Liu L; Ding Z
FEBS J; 2020 Dec; 287(24):5464-5477. PubMed ID: 32128976
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer.
Kouyama Y; Masuda T; Fujii A; Ogawa Y; Sato K; Tobo T; Wakiyama H; Yoshikawa Y; Noda M; Tsuruda Y; Kuroda Y; Eguchi H; Ishida F; Kudo SE; Mimori K
Cancer Sci; 2019 Oct; 110(10):3132-3144. PubMed ID: 31390121
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein A12A activates migration of hepatocellular carcinoma cells in a monocarboxylate transporter 4-dependent manner.
Min X; Cheng H; Cao X; Chen Z; Zhang X; Li Y; Mao Q; Xue B; Fang L; Liu L; Ding Z
Cell Stress Chaperones; 2022 Jan; 27(1):83-95. PubMed ID: 35050463
[TBL] [Abstract][Full Text] [Related]
16. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
[TBL] [Abstract][Full Text] [Related]
17. Molecular and genetic studies imply Akt-mediated signaling promotes protein kinase CbetaII alternative splicing via phosphorylation of serine/arginine-rich splicing factor SRp40.
Patel NA; Kaneko S; Apostolatos HS; Bae SS; Watson JE; Davidowitz K; Chappell DS; Birnbaum MJ; Cheng JQ; Cooper DR
J Biol Chem; 2005 Apr; 280(14):14302-9. PubMed ID: 15684423
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circRHOBTB3 represses metastasis by regulating the HuR-mediated mRNA stability of PTBP1 in colorectal cancer.
Chen J; Wu Y; Luo X; Jin D; Zhou W; Ju Z; Wang D; Meng Q; Wang H; Fu X; Xu J; Song Z
Theranostics; 2021; 11(15):7507-7526. PubMed ID: 34158864
[No Abstract] [Full Text] [Related]
19. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
[TBL] [Abstract][Full Text] [Related]
20. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
